In this study, we evaluated the function of IL13Rα2 associated with the castration resistance of prostate cancer and explored its clinical utility as a tissue and serum biomarker for predicting castration resistance in prostate cancer patients. This evidence concerns the gene IL13RA2 and Familial prostate cancer.